Market Alert: Fed Cut Hopes Lift ASX After Rough Week

Frequently Asked Questions

Click on the 'Start Your 7 Days Free Trial' button, fill out your details, and you’ll get instant access to our research reports without needing a credit card.

Yes, you can cancel your subscription anytime from your account dashboard without any hidden charges.

We cover ASX-listed stocks with a focus on growth, dividend, and sector-specific opportunities such as lithium, uranium, and gold.

Yes. Our Daily Dose delivers concise investment highlights with clear buy/hold/sell guidance and market insights.

Our analysts publish fresh research daily and update reports regularly when significant market events occur.

Yes. We specialise in identifying high-potential ASX small-cap and emerging companies before they hit the mainstream.

Full stock reports are available to subscribers. Simply log in to your account and visit the Research section.

We provide stock insights and sector analysis. However, we do not offer personalised financial advice or portfolio management.

The Daily Dose is our flagship daily market insight — a short, actionable report highlighting one stock or theme investors should watch.

Yes, Kapitales Research complies with all relevant financial research and publishing standards under ASIC guidelines.

No. We provide independent research and market insights. You should consult a licensed financial advisor before making investment decisions.

No. We provide independent research and market insights. You should consult a licensed financial advisor before making investment decisions.

We specialise in energy, mining, technology, healthcare, and financials, with a strong focus on ASX-listed companies.

Yes. We offer a refund policy as per our Terms & Conditions. Please contact support within the eligible time frame.

Yes, we provide corporate subscription packages tailored for teams and institutions. Contact us for details.